IL17A and neoplasm: Interaction of microbes with recruited myeloid cells and tumor cells elicits IL-23/IL-17 signaling that promotes tumor growth and initiates a feed-forward cycle, reprogramming of tight junctions to further reduce epithelial barrier permeability [23, 42, 43].